From USFDA
Alembic Pharmaceuticals has received approval for its abbreviated new drug application (ANDA) for Telmisartan and Amlodipine Tablets, 40mg/5mg, 40mg/10mg, 80mg/5mg and 80mg/10mg from the United States Food and Drug Administration. The tablets are indicated for the treatment of hypertension, alone or with antihypertensive agents to reduce blood pressure.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
